Effect of atorvastatin combined with benazepril on proteinuria of patients with IgA nephropathy

Abstract

Objective To investigate the efficacy and safety of atorvastatin combined with benazepril in the treatment of proteinuria in patients with IgA nephropathy, so as to provide guidance for clinical medication. Methods Eighty patients with IgA nephropathy were selected, and they were randomly divided into the observation group and control group according to random number table, with 40 patients in each group.The observation group was treated with atorvastatin combined with benazepril, and the control group was treated with benazepril.The treatment effect of the two groups was compared. Results Before treatment, the 24h urinary protein, mean arterial pressure, serum creatinine, blood urea nitrogen, and blood potassium between the two groups had no statistically significant differences (t=0.125, 1.273, 0.321, 0.207, 0.719, all P>0.05). After treatment, the 24h urine protein and mean arterial blood pressure in the two groups were lower than those before treatment, and the differences were statistically significant (t=2.735, 6.145, 3.434, 4.501, all P 0.05). Conclusion Atorvastatin combined with benazepril in the treatment of IgA nephropathy can significantly decrease urinary protein level, without the adverse reactions of increased urea nitrogen, creatinine and hyperkalemia, which is worthy of popularization and application. Key words: Glomerulonephritis, IgA; Atorvastatin; Benazepril; Proteinuria